
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Preclinical
Recipient : Neoregen Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
Circio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration
Details : The collaboration between Circio Holding ASA and NeoRegen Biotech is focused on advancing circular RNA (circRNA) expression-based therapeutics toward clinical readiness.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
June 30, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Preclinical
Recipient : Neoregen Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
